Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Ovid Therapeutics Inc (OVID)

  • Technical Exchange News
  • Sept. 12, 2025, 18:39 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mersana Therapeutics (MRSN)

  • Technical Exchange News
  • Sept. 12, 2025, 18:39 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

InflaRx N.V. (IFRX)

  • Technical Exchange News
  • Sept. 12, 2025, 18:38 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Healthcare Triangle Inc (HCTI)

  • Technical Exchange News
  • Sept. 12, 2025, 18:38 UTC
  • 40
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

DarioHealth Corp (DRIO)

  • Technical Exchange News
  • Sept. 12, 2025, 18:38 UTC
  • 39
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 08:20 UTC
  • 43
  • 0 comments

Cyclacel Pharmaceuticals Inc. (CYCCP) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Sept. 12, 2025, 08:20 UTC
  • 40
  • 0 comments

DURECT Corporation (DRRX) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • Sept. 12, 2025, 08:20 UTC
  • 42
  • 0 comments

Cyclacel Pharmaceuticals Inc. (CYCC) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: BioSig Technologies, Inc. - Common Stock.

Comment Full text
  • Previous
  • 83
  • 84
  • 85
  • 86
  • 87
  • Next

Search

News categories

  • Technical Exchange News(10868)
  • Event(2238)
  • SEC News(188884)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124452)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin